| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,560 |
5,198 |
$211K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,115 |
3,003 |
$201K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,088 |
1,042 |
$56K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
645 |
615 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
786 |
767 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
335 |
326 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
502 |
473 |
$13K |
| 87428 |
|
215 |
212 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
419 |
404 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
184 |
90 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
23 |
13 |
$1K |
| 20610 |
|
38 |
24 |
$526.78 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
32 |
28 |
$264.72 |
| 87420 |
|
13 |
13 |
$126.59 |
| 81003 |
|
28 |
27 |
$59.96 |
| 1125F |
|
13 |
13 |
$0.04 |